Sort
16,300 grants matching “fatty liver disease”
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals
$707,087Zdenek Hel · University Of Alabama At Birmingham · R01 · FY2023 · DK
KLF14 and Atherosclerosis
$706,887Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2019 · HL
KLF14 and Atherosclerosis
$706,887Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
Animal Models for Studying the Genetics of Hypertension
$706,633Oliver Smithies · Univ Of North Carolina Chapel Hill · R01 · FY2011 · HL
The macro- and micro- anatomy and pathology of the aging kidney
$706,523Andrew D Rule · Mayo Clinic Rochester · R01 · FY2011 · DK
Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseases
$706,502Alexander Revzin · Mayo Clinic Rochester · R01 · FY2023 · DK
Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification
$706,296Chiara Fabris · University Of Virginia · R01 · FY2023 · DK
The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity
$706,249David George Ashbrook · University Of Tennessee Health Sci Ctr · R01 · FY2024 · AG
Futuros Fuertes 2.0: A primary care-based intervention to prevent obesity in low-income Latino children
$706,087Amy Laura Beck · University Of California, San Francisco · R01 · FY2023 · HD
COLLOIDAL IRON-OXIDE NANOBEACONS FOR THERANOSTIC USE IN ATHEROSCLEROSIS
$705,598Gregory M Lanza · Washington University · R01 · FY2009 · HL
Colorado Center for Childhood Liver Disease Research and Education
$705,265Ronald J Sokol · University Of Colorado Denver · U01 · FY2011 · DK
The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism
$705,251Michael Karin · University Of California, San Diego · R01 · FY2022 · DK
Understanding and Targeting the Pathophysiology of Youth-onset Type2 Diabetes
$705,245Michael I Goran · Children'S Hospital Of Los Angeles · U01 · FY2025 · DK
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
$705,013Andrea A. Kovacs · University Of Southern California · R01 · FY2018 · DA
Nuclear receptors: action, functions, and roles in disease
$704,937Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Human population based genetic studies to elucidate the biology of NAFLD
$704,811Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2017 · DK
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals
$704,750Zdenek Hel · University Of Alabama At Birmingham · R01 · FY2024 · DK
Vitamin C (ascorbic acid) recommended dietary ingestion
$704,429Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Vitamin E Pharmacokinetics And Biomarkers In Normal And Obese Women
$704,429Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
$704,322Karen K Miller · Massachusetts General Hospital · R01 · FY2024 · DK
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
$704,301Jordan E Lake · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · DK
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics
$704,221Sonia Michael Najjar · Ohio University Athens · R01 · FY2020 · MD
CVD in American Indians Biomarker lab and Arizona Field Center
$703,961Barbara V Howard · Medstar Health Research Institute · R01 · FY2014 · HL
Imaging the Vascular Consequences of Lipid Deposition
$703,864James Athur Hamilton · Boston University Medical Campus · P50 · FY2007 · HL
Shape up! Kids
$703,842John Alan Shepherd · University Of California, San Francisco · R01 · FY2017 · DK